News

Tea Recalled Nationwide as FDA Sets Risk Level
A supplier provided "incorrect ingredients" for the items sold across the United States, Mexico and Ecuador, the FDA said.
Nationwide sweetener recall update as FDA issues risk warning
NuNaturals, Inc. initiated a voluntary recall for select lots of its Organic Pure Stevia and Pure Monk Fruit Sweetener on ...
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices ...
FDA Approves Vizz Eye Drops to Improve Near Vision in Adults
Vizz is the first and only aceclidine-based eye drop to improve near vision in adults with presbyopia. Vizz contracts the ...
US FDA approves Jazz Pharma's drug for rare brain tumor
The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' drug to treat diffuse ...
Medpage Today on MSN13h
FDA Approves Brain Tumor Drug Targeting New Mutation
The FDA granted accelerated approval to dordaviprone (Modeyso) as the first systemic therapy for adults and children with ...
FDA Issues Highest Risk Warning For Nuts
Navarro Pecan Holdings, LLC issued a voluntary recall of 32,670 pounds of pecan products on July 10 due to concerns about ...
The FDA Boss on the Agency’s MAHA Makeover
Dr. Marty Makary has criticized the Food and Drug Administration for being "captured" by Big Food and Big Pharma. Now, the ...
FDA raises recall of 64,800 lbs. of butter to second-highest warning level
Missouri-based food company Bunge North America has recalled 64,800 pounds - the equivalent of 1,800 cases - of its NH ...
The FDA is targeting orange juice. Here’s why, and what the science says.
Orange juice, known for its tangy, sweet taste, could be made with slightly less sugary oranges under a regulation proposed ...
New Atlas10h
FDA approves breakthrough eye drops that fix near vision without glasses
The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...
Vertex falls after FDA doubts broad use of chronic pain drug
Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...